StockData
SILONasdaqPharmaceutical PreparationsFiscal year ends December 31

Silo Pharma, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$1.13−0.05 (-4.24%)

Close on Oct 19, 2026

Market cap
$1.24M
P/E (TTM)
–
Dividend yield
–

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
9.0%
0M of 2M shares
Institutional holders
8
8 new, 0 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
6 buys · 0 sales
Net bought $7.66K

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Moez Kassam952,3817.20%13G (passive)Sep 30, 2025
AdvisorShares Trust75,5826.69%13G (passive)Jun 30, 2026
Daniel B. Asher1,478,1649.99%13G (passive) amendmentDec 31, 2025
Intracoastal Capital LLC1,384,4109.99%13G (passive) amendmentSep 30, 2025
Mitchell P. Kopin125,2619.99%13G (passive) amendmentJun 30, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of SILOValueChange% of portfolio
AdvisorShares Investments LLC75,5824.76%$469.36KNew0.06%
FNY Investment Advisers, LLC37,5072.36%$232New0.08%
Citadel Advisors LLC16,8001.06%$104.33KNew0.00%
Vanguard Capital Management LLC11,9560.75%$74.25KNew0.00%
Vanguard Fiduciary Trust Co8740.06%$5.43KNew0.00%
Tower Research Capital LLC (TRC)1810.01%$1.12KNew0.00%
Harbour Investments, Inc.140.00%$87New0.00%
Citigroup Inc10.00%$6New0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 202680M9.0%8 / 00 / 00M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

FundShares% of SILOValue% of fundAs of
AdvisorShares Psychedelics ETF75,5824.76%$469.36K1.06%Jun 30, 2026
Vanguard Extended Market Index Fund11,9560.75%$74.25K0.00%Jun 30, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Eric WeisblumChief Executive Officer, Director214,43213.50%Dec 16, 2025
Daniel E. RyweckChief Financial Officer5,0000.31%May 27, 2025
Wayne LinsleyDirector––May 27, 2025
Kevin MunozDirector––May 27, 2025
Jeff PavellDirector––May 27, 2025

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Eric Weisblum
Chief Executive Officer, Director
Dec 15, 2025Buy+2,500$0.41$1.03K214,432
Eric Weisblum
Chief Executive Officer, Director
Dec 15, 2025Buy+2,500$0.42$1.05K216,932
Eric Weisblum
Chief Executive Officer, Director
Nov 21, 2025Buy+1,000$0.37$370211,932
Eric Weisblum
Chief Executive Officer, Director
Nov 20, 2025Buy+1,000$0.37$370210,932
Eric Weisblum
Chief Executive Officer, Director
Nov 19, 2025Buy+4,500$0.41$1.85K209,932
Eric Weisblum
Chief Executive Officer, Director
Nov 18, 2025Buy+7,500$0.40$3.00K205,432
Eric Weisblum
Chief Executive Officer, Director
May 27, 2025Buy+10,000$0.43$4.30K197,932
Eric Weisblum
CEO and President, Director
Dec 13, 2024Buy+2,500$0.84$2.10K187,932
Eric Weisblum
CEO and President, Director
Nov 22, 2024Buy+2,500$0.90$2.25K185,432
Eric Weisblum
CEO and President, Director
Nov 20, 2024Buy+2,500$0.95$2.38K182,932
Eric Weisblum
CEO and President, Director
Jun 12, 2024Buy+4,438$1.11$4.93K180,432
Eric Weisblum
CEO and President, Director
Jun 11, 2024Buy+562$1.08$607175,994
Eric Weisblum
CEO and President, Director
Apr 5, 2024Buy+400$2.03$812175,432
Eric Weisblum
CEO and President, Director
Apr 4, 2024Buy+600$1.96$1.18K175,032
Eric Weisblum
CEO and President, Director
Apr 1, 2024Buy+1,100$1.91$2.10K174,432
Eric Weisblum
CEO and President, Director
Mar 28, 2024Buy+3,408$1.94$6.61K173,332
Eric Weisblum
CEO and President, Director
Dec 20, 2023Buy+200$1.61$322169,924
Eric Weisblum
CEO and President, Director
Dec 19, 2023Buy+500$1.63$815169,724
Eric Weisblum
CEO and President, Director
Dec 15, 2023Buy+900$1.52$1.37K169,224
Eric Weisblum
CEO and President, Director
Dec 14, 2023Buy+200$1.50$300168,324
Eric Weisblum
CEO and President, Director
Dec 7, 2023Buy+324$1.36$441168,124
Eric Weisblum
CEO and President, Director
Dec 6, 2023Buy+76$1.34$102167,800
Eric Weisblum
CEO and President, Director
Dec 5, 2023Buy+600$1.39$834167,724
Eric Weisblum
CEO and President, Director
Nov 30, 2023Buy+1,000$1.53$1.53K167,124
Eric Weisblum
CEO and President, Director
Nov 29, 2023Buy+1,000$1.57$1.57K166,124
Eric Weisblum
CEO and President, Director
Nov 27, 2023Buy+250$1.78$445165,124
Eric Weisblum
CEO and President, Director
Nov 22, 2023Buy+400$1.68$672164,874
Eric Weisblum
CEO and President, Director
Nov 21, 2023Buy+300$1.56$468164,474
Eric Weisblum
CEO and President, Director
Nov 20, 2023Buy+4,050$1.60$6.48K164,174
Eric Weisblum
CEO and President, Director
Nov 17, 2023Buy+1,800$1.54$2.77K160,124
Eric Weisblum
CEO and President, Director
Nov 16, 2023Buy+1,100$1.33$1.46K158,324
Daniel E. Ryweck
Chief Financial Officer
May 26, 2023Buy+1,000$2.13$2.13K5,000
Eric Weisblum
CEO and President, Director
May 18, 2023Buy+500$2.11$1.06K157,724
Eric Weisblum
CEO and President, Director
May 17, 2023Buy+2,500$2.06$5.15K157,224
Eric Weisblum
CEO and President, Director
Dec 20, 2022Buy+130$2.72$354154,854
Eric Weisblum
CEO and President, Director
Dec 19, 2022Buy+200$2.68$536154,724
Eric Weisblum
CEO and President, Director
Dec 14, 2022Buy+263$3.17$834154,524
Eric Weisblum
CEO and President, Director
Dec 13, 2022Buy+487$3.07$1.50K154,261
Eric Weisblum
CEO, CFO and President, Director
Jun 17, 2022Buy+13,080$0.11$1.44K7,724,643
Eric Weisblum
Chief Executive Officer, Director
Dec 13, 2021Buy+17,500$0.14$2.45K7,711,563
Eric Weisblum
Chief Executive Officer, Director
Dec 10, 2021Buy+5,000$0.16$8007,694,063
Eric Weisblum
CEO, CFO and President, Director
Apr 28, 2020Award+7,630,949––7,689,063
Eric Weisblum
CHIEF EXECUTIVE OFFICER, Director
Apr 17, 2020Award+7,630,949––7,988,663
Eric Weisblum
CEO, CFO and President, Director
Oct 22, 2019Buy+200$0.45$9058,114
Eric Weisblum
CEO, CFO and President, Director
Oct 15, 2019Buy+200$0.38$7657,914
Eric Weisblum
CEO, CFO and President, Director
Jun 17, 2019Buy+57,714––57,714
Eric Weisblum
Pres, Chief Compliance Officer, Director
Sep 4, 2014Gift−3,584,160$1.00$3.58M0
Van Eps Parker
Director
Jul 30, 2014Award+37,500––37,500
Eric Weisblum
President and CCO, Director
Jun 20, 2013Award+3,584,160––3,584,160
Richard Brand
Chairman and CEO, Director
Jun 20, 2013Award+2,042,080––2,042,080

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.